预防ASCVD事件:使用冠状动脉化得分来个性化风险和指导类药物治疗
Joel Kupfer1, Helme Silvet2, Samuel M Aguayo1
1Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Arizona.
概括
使用低剂量CT扫描的肺癌查 (LCS) 可以识别冠状动脉化 (CAC) 风险. 这有助于预防高风险吸烟者的动脉样硬化心血管疾病 (ASCVD) 事件.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 放射学 放射学是指放射学
背景情况:
- 肺癌是癌症死亡的主要原因之一,吸烟是主要的危险因素.
- 肺癌风险较高的吸烟者也面临着动脉样硬化心血管疾病 (ASCVD) 发病率和死亡率的重大风险.
- 肺癌查 (LCS) 为ASCVD事件预防提供了一个机会.
研究的目的:
- 审查使用冠状动脉化 (CAC) 评分用于初级预防的临床差异,以及在接受LCS的吸烟者中接受他类药物治疗的指导.
- 为在LCS环境中将CAC分数纳入ASCVD风险管理提供建议.
主要方法:
- 对LCS中低剂量计算机断层扫描 (LDCT) 的CAC评分现有文献的审查.
- 对吸烟者与普通人群的CAC分数解释差异的分析.
- 在LCS期间对ASCVD预防策略的综合建议.
主要成果:
- 用于LCS的LDCT扫描可以揭示CAC的程度,这是一个独立的ASCVD风险因素.
- 与一般人群相比,CAC评分的解释及其在指导初级预防和他类药物治疗中的应用对于符合LCS条件的吸烟者不同.
- 将CAC发现集成到LCS协议中可以增强ASCVD风险分层.
结论:
- 在LCS期间从LDCT获得的CAC得分可以为ASCVD事件预防策略提供信息.
- 建议提供了利用CAC得分,结合心脏检测,并确定需要心血管专家转诊的LCS患者.
- 在LCS计划中优化ASCVD风险管理对于高风险吸烟者至关重要.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Coronary Artery Disease IV: Medical Management
4
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
4
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Atherosclerosis II: Clinical manifestations and prevention
2
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2


